ASC expression and methylation status in lung cancer [i.e., small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC)], were evaluated in three studies (Virmani et al., 2003; Machida et al., 2006; Zhang et al., 2006). Here, PYCARD is linked to small cell lung carcinoma.